Charles J. Schleupner
- Epidemiology top 10%
- Infectious Diseases top 10%
- Molecular Medicine top 10%
- Critical Care and Intensive Care Medicine top 5%
- Pharmacology
- Co-authors
- S J SperberL. A. GlasgowJohn R. HamiltonJohn A. ArmstrongM. HoDavid S. KrauseVinod K. RustgiJames C. Overall
- Topics
- Antibiotics Pharmacokinetics and Efficacy (8 papers)Pneumonia and Respiratory Infections (7 papers)Antibiotic Resistance in Bacteria (7 papers)
- Cited by
- Molecular MedicineCritical Care and Intensive Care MedicineApplied Microbiology and Biotechnology
- Partner nations
- United States
In The Last Decade
Charles J. Schleupner
30 papers receiving 499 citations
Peers
Comparison fields: 5 of 82
- Epidemiology 287
- Infectious Diseases 197
- Molecular Medicine 70
- Critical Care and Intensive Care Medicine 68
- Pharmacology 65
Countries citing papers authored by Charles J. Schleupner
This map shows the geographic impact of Charles J. Schleupner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles J. Schleupner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles J. Schleupner more than expected).
Fields of papers citing papers by Charles J. Schleupner
This network shows the impact of papers produced by Charles J. Schleupner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles J. Schleupner. The network helps show where Charles J. Schleupner may publish in the future.
Co-authorship network of co-authors of Charles J. Schleupner
This figure shows the co-authorship network connecting the top 25 collaborators of Charles J. Schleupner. A scholar is included among the top collaborators of Charles J. Schleupner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles J. Schleupner. Charles J. Schleupner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 12 | |
| 3 | 37 | |
| 4 | 18 | |
| 5 | 18 | |
| 6 | 36 | |
| 7 | A multicenter trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults. | 12 |
| 8 | 2 | |
| 9 | 123 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 9 | |
| 14 | 24 | |
| 15 | 15 | |
| 16 | 12 | |
| 17 | 32 | |
| 18 | 2 | |
| 19 | 37 | |
| 20 | 13 |
About Charles J. Schleupner
Charles J. Schleupner is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases, having authored 30 papers that have together received 562 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Molecular Medicine (70 citations), Critical Care and Intensive Care Medicine (68 citations) and Applied Microbiology and Biotechnology (25 citations). Charles J. Schleupner has collaborated with scholars based in United States. Frequent co-authors include S J Sperber, L. A. Glasgow, John R. Hamilton, John A. Armstrong, M. Ho, David S. Krause, Vinod K. Rustgi, James C. Overall, Jean A. Smith and Thomas M. Kerkering. Their work appears in journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.